We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

CytRx Contributes $15 Million net to Majority-Owned RNAi Subsidiary RXi Pharmaceuticals

News   May 02, 2007

 
CytRx Contributes $15 Million net to Majority-Owned RNAi Subsidiary RXi Pharmaceuticals
 
 
 

RELATED ARTICLES

Ancient Worm Reveals a Way To Destroy Toxic Cells in Huntington's Disease

News

A highly conserved mechanism in worms and humans has been identified, that controls the removal of toxic protein aggregates – hallmarks of neurodegenerative diseases. Insights from their study may provide a novel therapeutic approach for Huntington's and Parkinson's disease.

READ MORE

Wrinkles on the Skin of a Worm May Hold the Key to a Longer, Healthier Life for Humans

News

Working with Caenorhabditis elegans, a transparent nematode found in soil, researchers were the first to find that the nervous system controls the tiny worm's cuticle, a skin-like exterior barrier, in response to bacterial infections.

READ MORE

A Change in Cell Logistics Helps Cancer Become Resistant

News

Researchers have discovered that breast cancers which had become resistant to hormone therapy have a molecular "advantage" that helps the cells successfully evade hormone therapies.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE